LOS ANGELES, 17 April 2019 – ImaginAb Inc., a clinical stage immuno-oncology imaging company, today announces that it is scheduled to present at the following investor and scientific conferences in April and May 2019.
AIM at Melanoma
April 26-28, 2019, Hotel L’Echiquier Opera Paris, 38 Rue De L Echiquier, Paris
Dr. Anna Wu, Founder, and Board Director, and Ivan Plavec, CBO will be attending and making a presentation on ImaginAb at the 26th International Myeloma Working Group meeting in Paris.
Anglo-Nordic Life Science Conference
May 9, 2019, The County Hall, Belvedere Road, London
Ian Wilson, CEO, will be a panelist at the ‘Technologies and Treatments – What’s on the horizon’ discussion at 13.30 BST.
Bio€quity Europe 2019
May 20-21, 2019, Crowne Plaza Fira Center, Barcelona
Ian Wilson, CEO, and Ivan Plavec, CBO, will be attending and hosting meetings.
2019 ASCO Annual Meeting
May 31-June 4, 2019, McCormick Place, Chicago
Ian Wilson, CEO, Ivan Plavec, CBO, and Ron Korn CMO, will be attending and hosting meetings.
Phone: +1 310 645 1211
Optimum Strategic Communications
Mary Clark, Supriya Mathur
Phone: +44 20 3950 9144
ImaginAb Inc. is an immuno-oncology imaging company focused on providing actionable insight into patient selection and treatment progress for cancer immunotherapy, enabling precision medicine. ImaginAb engineers antibody fragments called minibodies that maintain the exquisite specificity of full-length antibodies while remaining inert in the body. Used with widely available PET scan technology, these novel minibodies illuminate high-value molecular targets, providing physicians with a whole-body picture of immune activity. ImaginAb is also developing a pipeline for other targets in oncology. ImaginAb’s products have the potential to improve patient care and lower healthcare costs.
For more information about ImaginAb’s pipeline and technology, visit www.imaginab.com.